Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 526953 | NSE Symbol : VENUSREM | ISIN : INE411B01019 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Jan-2025	04-Feb-2025	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve Board meeting scheduled to be held on 04th February 2025 This has reference to the meeting of Board of Directors held on 4th February 2025 inter alia considered and approved: 1. Unaudited Financial Results for the quarter and nine months ended on 31st December 2024 along with Limited Review report. 2. The Board of Directors of the Company, based on a legal opinion, has resolved to write off the time-barred unsecured Foreign Currency Convertible Bond (FCCB) liability of ?38.68 crores including interest, which has remained unclaimed for over 10 years and is no longer legally enforceable under applicable laws. (As Per Bse Announcement Dated on 04.02.2025)
29-Nov-2024	29-Nov-2024	Subsidiary Company	Board approved the establishment of wholly owned subsidiary in Hungary by its wholly owned subsidiary Venus Pharma GmbH, Germany
18-Oct-2024	29-Oct-2024	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Boar meeting is scheduled for 29th October 2024 to inter alia consider and approve Unaudited financial results for the period ended on 30th September 2024. Outcome of Board meeting dated 29.10.24 (As per BSE Announcement Dated on 29/10/2024)
01-Aug-2024	13-Aug-2024	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the period ended on 30th June 2024. 2. To consider the appointment of independent director(s). 3. To finalize the date of 35th Annual General Meeting of the company. 4. Any other business with permission of the Chair. outcome as per the pdf attached. (As Per Bse Announcement Dated on 13.08.2024)
10-Jul-2024	20-Jul-2024	Change in Directors	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 20th July 2024 inter alia: 1. To consider the appointment of independent director. 2. To finalize the date of 35th Annual General Meeting of the company. 3. Any other business with permission of the Chair. The Board Meeting to be held on 20/07/2024 Stands Cancelled. This is to inform you that the meeting of Board of Directors which was scheduled 20th July 2024 has been postponed till further notice due to non-availability of quorum. (As Per BSE Announcement Dated on 17.07.2024)
18-May-2024	30-May-2024	Accounts	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve 1. Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March 2024. 2. Any other business with the permission of Chair.
02-Feb-2024	14-Feb-2024	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the period ended on 31st December 2023. 2. Any other business with the permission of Chair. Financial Results for the period ended on 31st December 2023. (As Per BSE Announcement Dated on: 14/02/2024)
28-Oct-2023	09-Nov-2023	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 09th November 2023 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th September 2023. 2. Any other business with the permission of Chair. This has reference to the meeting of Board of Directors held on 9th November 2023 inter alia considered and approved the Unaudited Financial Results for the period ended on 30th September 2023 along with Limited Review report. Unaudited Financial Results for the period ended on 30th September 2023 along with Limited Review report are enclosed herewith. (As Per BSE Announcement dated on 09.11.2023)
03-Aug-2023	14-Aug-2023	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 14th August 2023 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarfer ended on 30th June 2023. 2. Any other business with the permission of Chair. Unaudited financial results for the quarter ended on 30.06.2023. This has reference to the meeting of Board of Directors held on 14th August 2023 inter alia considered and approved the Unaudited Financial Results for the period ended on 30th June 2023 along with Limited Review report. Unaudited Financial Results for the period ended on 30th June 2023 along with Limited Review report are enclosed herewith. Meeting commenced at 04:30 pm and concluded at 07.05 pm. Kindly take the above information on your record. (As Per BSE Announcement dated on 14.08.2023)
05-Jul-2023	14-Jul-2023	Others	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/07/2023 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 14th July 2023 inter alia: 1. To consider the appointment of Statutory Auditor of the Company. 2. To finalize the date of 34th Annual General Meeting of the company. 3. Any other business with permission of the Chair. Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th July 2023 1. Appointment of M/s J.K. Jain & Associates as the Statutory Auditors of the Company subject to the approval of members in upcoming Annual General Meeting. The said appointment is resulting from completion of term of existing Statutory Auditors. 2. The date of 34th Annual general meeting as 24th August at 11:30 a.m. (1ST) through Video Conferencing ('VC') /Other Audio-Visual Means ('OAVM'). 3. The books closure (Register of Members and Share Transfer Books) for the purpose of 34th Annual General Meeting will commence from 18th August 2023 to 24th August 2023 (both days inclusive). 4. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on August 17, 2023. Any person, who is a member of the company as on August 17, 2023, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on August 21, 2023 (9:00 a.m.) and ends on August 23, 2023 (5 :00 p.m.). (As Per BSE Announcement Dated on 14.07.2023)
17-May-2023	29-May-2023	Accounts	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 29th May 2023 inter alia: 1. To consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March 2023. 2. Any other business with the permission of Chair. Audited Financial Results for the quarter and year ended on 31st March 2023 along with Limited Review report. 2. the appointment Mr. NPS Monga as an Additional Director (Non- Executive Independent Director) w.e.f. 29th May 2023 to hold office till the conclusion of the next General Meeting of the Company and will be appointed as regular Independent Non -Executive Director for five consecutive years, subject to approval of members in the next General Meeting. (As Per BSE Announcement Dated on 29.05.2023) Board approved:- 1. the appointment Mr. NPS Monga as an Additional Director (Non-Executive Independent Director) w.e.f. 29th May 2023 to hold office till the conclusion of the next General Meeting of the Company and will be appointed as regular Independent Non -Executive Director for five consecutive years, subject to approval of members in the next General Meeting (As Per BSE Bulletin Dated on 20.06.2023)
19-Jan-2023	30-Jan-2023	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and period ended on 31st December 2022. 2. Any other business with the permission of Chair. This has reference to the meeting of Board of Directors held on 30th January 2023 inter alia considered and approved the Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report. Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report are enclosed herewith. Meeting commenced at 04:30 pm and concluded at 07.48 pm. Kindly take the above information on your record. Please find enclosed herewith Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report which were taken on record by the Board of Directors at its meeting held on 30th January 2023. (As per BSE Announcement Dated on 30/01/2023)
02-Nov-2022	12-Nov-2022	Quarterly Results	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 12th November 2022 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended on 30th September 2022. 2. Any other business with the permission of Chair. This has reference to the meeting of Board of Directors held on 12th November 2022 inter alia considered and approved the Unaudited Financial Results for the half year and quarter ended on 30th September 2022 along with Limited Review report. Unaudited Financial Results for the half year and quarter ended on 30th September 2022 along with Limited Review report are enclosed herewith. Meeting concluded at 07:40 pm. Kindly take the above information on your record (As Per BSE Announcement Dated 12.11.2022)
25-Jul-2022	30-Jul-2022	Quarterly Results	Quarterly Results Outcome of Board meeting dated 30.07.2022 Unaudited Financial Results for the quarter ended on 30th June 2022 along with Limited Review report. (As Per BSE Announcement Dated on 30/07/2022)
16-May-2022	27-May-2022	Accounts	VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 27th May 2022 inter alia: 1. To consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March 2022. 2. Any other business with the permission of Chair. As per Attachment. Financial Results for the quarter and year ended on 31st March 2022. (As Per BSE Announcement Dated on 27.05.2022) Please find enclosed herewith newspaper publication of Financial Results as on 31st March 2022. (As per BSE Announcement Dated on 28.05.2022)

1 2

LOGIN HERE

Venus Remedies Ltd

Board Meeting